Cervical Softening and the Prediction of Preterm Birth

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

390 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-18

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Currently, transvaginal cervical length measurement is used to screen in asymptomatic pregnant women with a history of PTB. In symptomatic women, presenting with threatened PTB cervical length in combination with the fibronectin test is used to identify women at high risk to deliver preterm. However, the predictive capacity of transvaginal cervical length measurement is limited. In pregnant women with a history of PTB, it only identifies a proportion of women who will have recurrent PTB. For symptomatic women, 30-60% of these women admitted to the hospital, do not deliver within seven days, leading to overtreatment of these women.

Cervical softening is precursor of cervical shortening, effacement and dilatation and therefore cervical softening is a promising new marker that is based on tissue elasticity. However, the predictive value of cervical softening and the relation with spontaneous PTB still has to be determined. With the newly developed Pregnolia® System cervical softness could be measured on a standardized and safe manner. This study could help to improve care for women with a history of spontaneous PTB.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Can Cervical Stiffness in the Second Trimester Predict Preterm Birth in High-Risk Singleton Pregnancies?

NCT05837390

Preterm Birth

COMPLETED

The Prognostic Value of Cervical Elastography for Identifying Patients at Risk for Preterm Delivery

NCT02021539

Obstetric Labor Labor Onset Obstetric Labor, Premature

TERMINATED

Impact of Pessary Treatment on Cervical Stiffness Measurement and Birth Outcomes in Patients at Risk for Preterm Birth

NCT05267717

Preterm Birth

UNKNOWN

Mapping the Uterine Cervix Stiffness of Pregnant Women at Mid Gestation

NCT05858775

Cervix; Pregnancy

RECRUITING

Does Fetal Fibronectin and Ultrasound Cervical Length Help in the Evaluation of Women With Suspected Preterm Labor?

NCT00371046

Preterm Birth

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Preterm birth (PTB) is amongst the leading causes of perinatal and childhood morbidity and mortality. Therefore, accurate identification of pregnant women at high risk of PTB is important. Identifying these women, enables obstetric healthcare professionals to apply interventions to postpone delivery and/or to prevent PTB to improve perinatal and childhood outcomes.

Currently, transvaginal cervical length measurement is used to screen asymptomatic pregnant women with a history of PTB to identify women requiring a cerclage. In symptomatic women, presenting with threatened (PTB), cervical length in combination with the fetal fibronectin(fFN) test is used to identify women at high risk to deliver within 7 days of presentation. However, the predictive capacity of transvaginal cervical length measurement is limited. In pregnant women with a history of PTB, it only identifies a proportion of women who will have recurrent PTB. For symptomatic women, 30-60% of these women admitted to the hospital, do not deliver within seven days, leading to overtreatment of these women.

Since cervical softening is a precursor of cervical shortening, effacement and dilatation, cervical softening is a promising new marker that is based on tissue elasticity. It can be measured with the CE-marked Pregnolia® System for accurate characterization of cervical softening status. It provides a value for tissue elasticity on a continuous scale.

A previous study has shown that softening of the cervix can be detected before shortening of the cervix. The Pregnolia® System may allow to detect women at risk for PTB earlier compared to traditional transvaginal ultrasound that measures shortening of the cervix, and therefore may prove useful for a more accurate risk assessment of PTB.

This current study is a single centre cohort study, where Two cohorts of women will be investigated. 1) Asymptomatic pregnant women with a history of spontaneous PTB before 34 weeks of gestation (Cohort A-STIPP). 2) Symptomatic women presenting with threatened PTB between 24 and 34 weeks (Cohort S-STIPP).

Objective: The aim of this study is to evaluate the predictive capacity of cervical softening and risk of PTB.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preterm Birth Threatened Preterm Labor Premature Birth Premature Labor Diagnosis Cervical Incompetence, With Delivery Cervical Incompetence in Pregnancy as Antepartum Condition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Asymptomatic women with a history of preterm birth

Pregnant women \>18 years of age, with a history of spontaneous PTB before 34 weeks. All women have biweekly visits for routine transvaginal cervical length measurement between 14-24 weeks of gestation. During these visits data on cervical softening will be collected as additional marker.

Measurement of cervical stiffness by Pregnolia Device

Intervention Type DIAGNOSTIC_TEST

The Pregnolia® System is designed to provide information about the mechanical properties of the cervical tissue by assessing the CSI (Cervical Stiffness Index) through a probe that will create a weak vacuum to retract tissue. The Pregnolia® System is designed with the purpose to provide an alternative diagnostic marker to identify women at risk of spontaneous PTB.

The Pregnolia® System is a CE-marked device developed for quantitative assessment of softening of the uterine cervix.

The Pregnolia® System will be applied within its intended use.

Symptomatic women with symptoms of threatened preterm birth

Pregnant women \>18 years of age, between 24 and 34 weeks of gestation, presenting with symptoms of threatened Preterm birth (e.g. abdominal pain, blood loss, contractions, or other complaints suggestive for threatened Preterm birth).

Measurement of cervical stiffness by Pregnolia Device

Intervention Type DIAGNOSTIC_TEST

The Pregnolia® System is designed to provide information about the mechanical properties of the cervical tissue by assessing the CSI (Cervical Stiffness Index) through a probe that will create a weak vacuum to retract tissue. The Pregnolia® System is designed with the purpose to provide an alternative diagnostic marker to identify women at risk of spontaneous PTB.

The Pregnolia® System is a CE-marked device developed for quantitative assessment of softening of the uterine cervix.

The Pregnolia® System will be applied within its intended use.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Measurement of cervical stiffness by Pregnolia Device

The Pregnolia® System is designed to provide information about the mechanical properties of the cervical tissue by assessing the CSI (Cervical Stiffness Index) through a probe that will create a weak vacuum to retract tissue. The Pregnolia® System is designed with the purpose to provide an alternative diagnostic marker to identify women at risk of spontaneous PTB.

The Pregnolia® System is a CE-marked device developed for quantitative assessment of softening of the uterine cervix.

The Pregnolia® System will be applied within its intended use.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years or above.
* Ability to understand Dutch or English (both spoken and written).
* Ultrasound-based gestational age determined by measurement of crown rump length (CRL) determined between 9 and 11 weeks of gestation.
* Singleton and twin pregnancies.

Cohort A-STIPP specific:

\- Medical history of spontaneous preterm birth before 34 weeks of gestation

Cohort S-STIPP specific:

* Threatened Preterm birth between 24 and 34 weeks of gestation.
* Threatened preterm birth is defined as:

* abdominal pain
* (Braxton Hicks) contractions
* vaginal blood loss.

Exclusion Criteria

* Under 18 years of age.
* Signs of intrauterine infection.
* Obstetric indication for immediate delivery (advanced labor, cord prolapse, abruption, signs of fetal distress).
* Confirmed fetal abnormality.
* Confirmed preterm rupture of membranes.
* Confirmed vasa / placenta praevia.
* Severe vaginal bleeding and light bleeding that cannot be stopped.
* Signs of imminent labor such as blood loss, regular contractions.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No